Walleye Capital
CL icon

Walleye Capital’s Colgate-Palmolive CL Stock Holding History

Walleye Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.4M Buy
51,600
+10,000
+24% +$891K 0.02% 885
2025
Q4 		$3.29M Buy
41,600
+8,700
+26% +$682K 0.01% 1465
2025
Q3 		$2.63M Sell
32,900
-24,400
-43% -$2.08M 0.01% 1374
2025
Q2 		$5.21M Sell
57,300
-100
-0.2% -$9.13K 0.02% 845
2025
Q1 		$5.38M Buy
57,400
+10,900
+23% +$976K 0.02% 736
2024
Q4 		$4.23M Sell
46,500
-40,600
-47% -$3.87M 0.01% 1195
2024
Q3 		$9.04M Sell
87,100
-65,200
-43% -$6.65M 0.02% 749
2024
Q2 		$14.8M Sell
152,300
-22,500
-13% -$2.08M 0.03% 523
2024
Q1 		$15.7M Buy
174,800
+44,500
+34% +$3.77M 0.03% 554
2023
Q4 		$10.4M Buy
130,300
+46,600
+56% +$3.5M 0.02% 650
2023
Q3 		$5.95M Buy
83,700
+29,700
+55% +$2.22M 0.02% 907
2023
Q2 		$4.16M Buy
54,000
+43,700
+424% +$3.38M 0.02% 851
2023
Q1 		$774K Buy
+10,300
New +$766K 0.01% 1349

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Walleye Capital's CL Position: Q1 2026 in Review

Walleye Capital increased its Colgate-Palmolive (CL) stake by 5,316% in Q1 2026, buying an estimated $7.7M and bringing the position to 88,008 shares worth $7.5M. The position accounts for 0.03% of the portfolio, ranked #548.

Walleye Capital first reported a position in CL in Q4 2021 and has held it in 13 quarters since. The position peaked at $23.2M in Q2 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Walleye Capital held 88,008 shares of Colgate-Palmolive worth $7.5M as of Q1 2026.
  • Walleye Capital bought 86,383 Colgate-Palmolive shares in Q1 2026, an estimated $7.7M.
  • Colgate-Palmolive made up 0.03% of Walleye Capital's portfolio in Q1 2026, its #548 holding.
  • Walleye Capital first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 13 quarters since.
  • Walleye Capital's Colgate-Palmolive position peaked at $23.2M in Q2 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.